Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Equivalent dose analysis of remimazolam and propofol for loss of consciousness during pediatric general anesthesia
ChiCTR2200067112Phase 4Not yet recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol (10 arms), sponsored by Shanghai Children's Medical Center. Primary endpoint: Time of loss of consciousness. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
remimazolampropofol
Beyond the preview
Go deeper on ChiCTR2200067112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200067112.